So, Erdafitinib is this drug that zeroes in on metastatic urothelial carcinoma, specifically the ones with changes in FGFR2/3. It works by stopping FGFR signaling. It’s available in tablets that are coated, and there are three dosages to choose from: 3mg, 4mg, and 5mg.
You typically start with 8 mg taken every day, but it’s okay to bump it up to 9 mg if you need to. They come in bottles that hold 56 tablets each.
Reviews
There are no reviews yet.